SE9800452D0 - Antivirals - Google Patents
AntiviralsInfo
- Publication number
- SE9800452D0 SE9800452D0 SE9800452A SE9800452A SE9800452D0 SE 9800452 D0 SE9800452 D0 SE 9800452D0 SE 9800452 A SE9800452 A SE 9800452A SE 9800452 A SE9800452 A SE 9800452A SE 9800452 D0 SE9800452 D0 SE 9800452D0
- Authority
- SE
- Sweden
- Prior art keywords
- antivirals
- hiv
- compounds
- independently
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (69)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800452A SE9800452D0 (sv) | 1998-02-13 | 1998-02-13 | Antivirals |
PL98338643A PL338643A1 (en) | 1997-08-15 | 1998-08-14 | Nucleosidic analoques such as antiviral ones comprising inhibitors of retrovirus revertase and dna polymerase of b type viral hepatic (hbv) |
JP2000509711A JP3844654B2 (ja) | 1997-08-15 | 1998-08-14 | レトロウイルス逆転写酵素およびb型肝炎ウイルス(hbv)のdnaポリメラーゼのインヒビターを含む抗ウイルス剤などのヌクレオシドアナログ |
IL13450398A IL134503A0 (en) | 1997-08-15 | 1998-08-14 | Nucleoside analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
KR10-2000-7001476A KR100529272B1 (ko) | 1997-08-15 | 1998-08-14 | 레트로바이러스 역전사효소 및 b형 간염바이러스(hbv)의 dna 중합효소의 억제제를 포함한항바이러스제와 같은 뉴클레오시드 유사체 |
NZ508502A NZ508502A (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
DK98939041T DK0988304T3 (da) | 1997-08-15 | 1998-08-14 | Nukleosidanaloger såsom antivirale midler omfattende inhibitorer af retroviral revers transkriptase og DNA-polymerasen fra hepatitis B-virus (HBV) |
TW087113427A TW580500B (en) | 1997-08-15 | 1998-08-14 | Nucleoside compounds, and pharmaceutical composition comprising same for use in the prophylaxis or treatment of viral infections |
AT01103370T ATE293112T1 (de) | 1997-08-15 | 1998-08-14 | 3'-fluorierte guanosinderivate zur behandlung oder prophylaxe von hbv- oder retroviralen infektionen |
TR2000/02273T TR200002273T2 (tr) | 1997-08-15 | 1998-08-14 | Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları. |
EP01103370A EP1123935B1 (en) | 1997-08-15 | 1998-08-14 | 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
CZ20000449A CZ300757B6 (cs) | 1997-08-15 | 1998-08-14 | Nukleosidové analogy, jako jsou antivirální cinidla obsahující inhibitory retrovirální reverzní transkriptázy a DNA polymerázy viru hepatitidy B (HBV) |
MYPI98003706A MY116269A (en) | 1997-08-15 | 1998-08-14 | 5' -aminocylated-2', 3' -dideoxy -3' -fluoroguanosine hbv antivirals |
CNB031579884A CN1286845C (zh) | 1997-08-15 | 1998-08-14 | 用作逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药的核苷类似物 |
EP98939041A EP0988304B1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
TR2000/00398T TR200000398T2 (tr) | 1997-08-15 | 1998-08-14 | Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları. |
SI9830031T SI0988304T1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
DE69800753A DE69800753D1 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
ES98939041T ES2158689T3 (es) | 1997-08-15 | 1998-08-14 | Analogos de nucleosidos, tales como antivirales, que incluyen inhibidores de transcriptasa inversa retroviral y la adn-polimerasa del virus de la hepatitis b (vhb). |
PCT/SE1998/001467 WO1999009031A1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
AT98939041T ATE200900T1 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
PT98939041T PT988304E (pt) | 1997-08-15 | 1998-08-14 | Analogos de nucleosidos tais como os antivirais que contem inibidores de transcritase reversa retroviral e de adn-polimerase do virus da hepatite b (hbv) |
ES01103370T ES2239637T3 (es) | 1997-08-15 | 1998-08-14 | Derivados de guanosina 3'-fluorados para el tratamiento o profilaxis de vhb o infecciones retrovirales. |
CN98810219A CN1130362C (zh) | 1997-08-15 | 1998-08-14 | 核苷类似物,这些化合物作为包括乙型肝炎病毒(hbv)的逆转录病毒的逆转录酶及dna聚合酶抑制剂的抗病毒药 |
NZ502837A NZ502837A (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
PL98366358A PL190284B1 (pl) | 1998-02-13 | 1998-08-14 | Analogi nukleozydowe, ich zastosowanie i zawierająca je kompozycja farmaceutyczna |
HU0100087A HU228060B1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, the use thereof for producing medicaments useful against retroviral infections and hepatitis b virus and the same medicaments |
DE69800753T DE69800753T4 (de) | 1997-08-15 | 1998-08-14 | Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus |
AU87548/98A AU728892B2 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV) |
CA002298704A CA2298704C (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
DE69829784T DE69829784T2 (de) | 1997-08-15 | 1998-08-14 | 3'-Fluorierte Guanosinderivate zur Behandlung oder Prophylaxe von HBV- oder retroviralen Infektionen |
SG200101048A SG96604A1 (en) | 1997-08-15 | 1998-08-14 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
PCT/SE1999/000189 WO1999041268A1 (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
US09/249,317 US6458772B1 (en) | 1909-10-07 | 1999-02-12 | Prodrugs |
EP99932499A EP1058687B1 (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
SI9930467T SI1058687T1 (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
AT99932499T ATE256140T1 (de) | 1998-02-13 | 1999-02-12 | Nucleoside |
IL13760599A IL137605A0 (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
CA002318975A CA2318975A1 (en) | 1998-02-13 | 1999-02-12 | Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine |
TR2000/02318T TR200002318T2 (tr) | 1998-02-13 | 1999-02-12 | Nükleositler |
JP2000531460A JP4413427B2 (ja) | 1998-02-13 | 1999-02-12 | ヌクレオシド |
MYPI99000515A MY121813A (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
ES99932499T ES2211116T3 (es) | 1998-02-13 | 1999-02-12 | Nucleosidos. |
DK99932499T DK1058687T3 (da) | 1998-02-13 | 1999-02-12 | Nukleosider |
KR1020007008862A KR100565388B1 (ko) | 1998-02-13 | 1999-02-12 | 뉴클레오시드 |
AU32819/99A AU732408B2 (en) | 1998-02-13 | 1999-02-12 | Nucleosides |
NZ506033A NZ506033A (en) | 1998-02-13 | 1999-02-12 | Nucleoside analogues useful for the inhibition of HBV and retroviruses |
HU0100879A HUP0100879A3 (en) | 1998-02-13 | 1999-02-12 | Nucleosides and their use for preparation of antiviral medicaments |
PT99932499T PT1058687E (pt) | 1998-02-13 | 1999-02-12 | Nucleosidos |
ZA9901148A ZA991148B (en) | 1998-02-13 | 1999-02-12 | Nucleosides. |
DE69913499T DE69913499T2 (de) | 1998-02-13 | 1999-02-12 | Nucleoside |
CNB998028851A CN1255422C (zh) | 1998-02-13 | 1999-02-12 | 核苷 |
IL13746899A IL137468A0 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
JP2000531466A JP2002503673A (ja) | 1998-02-13 | 1999-02-15 | プロドラッグ群 |
PCT/SE1999/000194 WO1999041275A1 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
EA200000838A EA002647B1 (ru) | 1998-02-13 | 1999-02-15 | Пролекарства |
AU32820/99A AU754733B2 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
CA002318978A CA2318978A1 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
EP99932500A EP1054891A1 (en) | 1998-02-13 | 1999-02-15 | Prodrugs |
IL134503A IL134503A (en) | 1997-08-15 | 2000-02-10 | Analogs of 2 '- Dioxy - 3' - Fluoroguanosine nucleoside and its uses in the preparation of drugs for the treatment of HBV and HIV infections |
IL137605A IL137605A (en) | 1998-02-13 | 2000-07-31 | '5 - O - [2, 3 - Bite - (L - Vileoxy and L - Isolocyloxy) - Propionyl] -' 2, '3 - Dioxy -' 3 - Fluoroguanosines and antiviral preparations containing them |
HK01103586A HK1032968A1 (en) | 1997-08-15 | 2001-05-23 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
GR20010400857T GR3036004T3 (en) | 1997-08-15 | 2001-06-06 | Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
US09/927,254 US20020128301A1 (en) | 1998-02-13 | 2001-08-10 | Non-nucleoside reverse transcriptase inhibitors |
HK01106601A HK1035907A1 (en) | 1998-02-13 | 2001-09-18 | Nucleosides |
US10/015,184 US6974802B2 (en) | 1998-02-13 | 2001-11-16 | Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine |
US11/202,682 US7071173B2 (en) | 1998-02-13 | 2005-08-12 | Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine |
US11/335,429 US7825238B2 (en) | 1998-02-13 | 2006-01-18 | Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine |
HK07103270.8A HK1097550A1 (en) | 1997-08-15 | 2007-03-27 | Antiviral nucleoside analogues as inhibitors of retroviral reverse transcriptase and dna polymerase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800452A SE9800452D0 (sv) | 1998-02-13 | 1998-02-13 | Antivirals |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9800452D0 true SE9800452D0 (sv) | 1998-02-13 |
Family
ID=20410196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9800452A SE9800452D0 (sv) | 1909-10-07 | 1998-02-13 | Antivirals |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1058687B1 (xx) |
JP (1) | JP4413427B2 (xx) |
KR (1) | KR100565388B1 (xx) |
CN (1) | CN1255422C (xx) |
AT (1) | ATE256140T1 (xx) |
AU (1) | AU732408B2 (xx) |
CA (1) | CA2318975A1 (xx) |
DE (1) | DE69913499T2 (xx) |
DK (1) | DK1058687T3 (xx) |
ES (1) | ES2211116T3 (xx) |
HK (1) | HK1035907A1 (xx) |
HU (1) | HUP0100879A3 (xx) |
IL (1) | IL137605A (xx) |
MY (1) | MY121813A (xx) |
NZ (1) | NZ506033A (xx) |
PL (1) | PL190284B1 (xx) |
PT (1) | PT1058687E (xx) |
SE (1) | SE9800452D0 (xx) |
SI (1) | SI1058687T1 (xx) |
TR (1) | TR200002318T2 (xx) |
WO (1) | WO1999041268A1 (xx) |
ZA (1) | ZA991148B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432966B2 (en) * | 1999-10-29 | 2002-08-13 | Smithkline Beecham Corporation | Antiviral combinations |
WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
EP1610797A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of nevirapine and a further antiretroviral compound |
EP1610781A1 (en) | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of tipranavir and a further antiretroviral compound |
DE10321905A1 (de) * | 2003-05-05 | 2004-12-09 | Eberhard-Karls-Universität Tübingen | Verwendung von Kombinationen aus Hemmern der reversen Transkriptase und Hemmern der viruscodierten DNA-Polymerase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8602981D0 (sv) * | 1986-07-04 | 1986-07-04 | Astra Laekemedel Ab | Novel medicinal use |
IL100874A (en) * | 1991-02-08 | 1996-01-19 | Pro Neuron Inc | Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them |
DE4311801A1 (de) * | 1993-04-09 | 1994-10-13 | Hoechst Ag | Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung |
US5543414A (en) * | 1994-07-28 | 1996-08-06 | Syntex (Usa) Inc. | Achiral amino acid acyl esters of ganciclovir and its derivatives |
-
1998
- 1998-02-13 SE SE9800452A patent/SE9800452D0/xx unknown
- 1998-08-14 PL PL98366358A patent/PL190284B1/pl not_active IP Right Cessation
-
1999
- 1999-02-12 NZ NZ506033A patent/NZ506033A/en not_active IP Right Cessation
- 1999-02-12 MY MYPI99000515A patent/MY121813A/en unknown
- 1999-02-12 AT AT99932499T patent/ATE256140T1/de not_active IP Right Cessation
- 1999-02-12 HU HU0100879A patent/HUP0100879A3/hu unknown
- 1999-02-12 DE DE69913499T patent/DE69913499T2/de not_active Expired - Fee Related
- 1999-02-12 EP EP99932499A patent/EP1058687B1/en not_active Expired - Lifetime
- 1999-02-12 CN CNB998028851A patent/CN1255422C/zh not_active Expired - Fee Related
- 1999-02-12 CA CA002318975A patent/CA2318975A1/en not_active Abandoned
- 1999-02-12 ZA ZA9901148A patent/ZA991148B/xx unknown
- 1999-02-12 SI SI9930467T patent/SI1058687T1/xx unknown
- 1999-02-12 DK DK99932499T patent/DK1058687T3/da active
- 1999-02-12 WO PCT/SE1999/000189 patent/WO1999041268A1/en active IP Right Grant
- 1999-02-12 PT PT99932499T patent/PT1058687E/pt unknown
- 1999-02-12 KR KR1020007008862A patent/KR100565388B1/ko not_active IP Right Cessation
- 1999-02-12 JP JP2000531460A patent/JP4413427B2/ja not_active Expired - Fee Related
- 1999-02-12 ES ES99932499T patent/ES2211116T3/es not_active Expired - Lifetime
- 1999-02-12 AU AU32819/99A patent/AU732408B2/en not_active Ceased
- 1999-02-12 TR TR2000/02318T patent/TR200002318T2/xx unknown
-
2000
- 2000-07-31 IL IL137605A patent/IL137605A/en unknown
-
2001
- 2001-09-18 HK HK01106601A patent/HK1035907A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY121813A (en) | 2006-02-28 |
ZA991148B (en) | 1999-08-12 |
JP4413427B2 (ja) | 2010-02-10 |
EP1058687B1 (en) | 2003-12-10 |
CN1290268A (zh) | 2001-04-04 |
HUP0100879A2 (hu) | 2002-04-29 |
TR200002318T2 (tr) | 2000-11-21 |
KR20010074428A (ko) | 2001-08-04 |
DE69913499T2 (de) | 2004-10-28 |
PT1058687E (pt) | 2004-03-31 |
AU3281999A (en) | 1999-08-30 |
ATE256140T1 (de) | 2003-12-15 |
DE69913499D1 (en) | 2004-01-22 |
PL190284B1 (pl) | 2005-11-30 |
CA2318975A1 (en) | 1999-08-19 |
WO1999041268A1 (en) | 1999-08-19 |
SI1058687T1 (en) | 2004-02-29 |
HUP0100879A3 (en) | 2002-08-28 |
AU732408B2 (en) | 2001-04-26 |
EP1058687A1 (en) | 2000-12-13 |
NZ506033A (en) | 2002-02-01 |
HK1035907A1 (en) | 2001-12-14 |
IL137605A (en) | 2006-12-31 |
JP2002503670A (ja) | 2002-02-05 |
CN1255422C (zh) | 2006-05-10 |
ES2211116T3 (es) | 2004-07-01 |
DK1058687T3 (da) | 2004-03-15 |
KR100565388B1 (ko) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100376A1 (ru) | Арилсульфонанилидмочевины | |
ATE374749T1 (de) | Indol-derivate als antientzündungs wirkstoffe | |
TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
SE9704709D0 (sv) | Pharmaceutically active compounds | |
NZ514453A (en) | Novel sulfonamide compounds and uses thereof | |
DE69713148D1 (de) | Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen | |
ATE297203T1 (de) | Antithrombotische mitteln | |
BR9604974A (pt) | Composição farmacêutica contendo benzimidazol para inibir o crescimento de canceres | |
MY123083A (en) | Acyclic nucleoside derivatives | |
CA2365495A1 (en) | Viral treatment | |
SE9800452D0 (sv) | Antivirals | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
CA2300289A1 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
TR199902019T2 (xx) | �kame edilmi� tiazolidion' un haz�rlanmas� i�in proses. | |
YU6396A (sh) | Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija | |
RS50033B (sr) | Derivati etansulfonil-piperidina | |
TR200100059T2 (tr) | Yeni antimikrobik bileşimler | |
SE0003795D0 (sv) | Pharmaceutically useful compounds | |
DE69600231D1 (de) | N-Arylalkylphenylacetamidderivate | |
DE69828390D1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
AP9801235A0 (en) | Erythromycin derivatives. | |
FI89594C (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefull pyrrolidinfoerening | |
SE9902271D0 (sv) | Pharmaceutically active compounds | |
SE9902596D0 (sv) | Pharmaceutically active compounds | |
TR200201141T2 (tr) | 2-Amino-3,4-dihidro-kinazolinlerin bir ilacın üretiminde kullanımı |